Medical imaging AI uses machine learning, especially deep learning, to analyze images from modalities such as X ray, CT, MRI, ultrasound and nuclear imaging. These systems learn patterns from large datasets and can support tasks like detection, classification, segmentation and prognosis.

Convolutional neural networks are central to image analysis, automatically extracting features for tasks like identifying tumors, lung nodules, fractures, brain lesions or cardiac abnormalities. More advanced architectures such as U Net and transformers enable precise segmentation of organs and lesions, which is crucial for radiotherapy planning, volumetric measurements and disease monitoring. Generative models can synthesize or enhance images, help with denoising, and even simulate missing modalities.

Clinical applications span many specialties. In oncology, AI supports early detection and characterization of cancers in breast, lung, liver, prostate and brain imaging, and can help predict response to therapy. In neurology, it assists in stroke detection, demyelinating disease assessment and neurodegenerative disease monitoring. In cardiology, AI helps quantify cardiac function and identify ischemia or structural disease.

Key challenges include data quality, labeling effort, dataset bias and generalization across scanners, protocols and populations. Robust validation, external testing and careful performance benchmarking are essential before deployment. Interpretability techniques such as saliency maps and attention visualization aim to make predictions more transparent. Regulatory approval, integration into clinical workflow and continuous monitoring of performance are critical for safe use.

Future directions emphasize multimodal models that combine imaging with clinical and genomic data, self supervised learning to reduce annotation needs, and AI tools designed to augment radiologists and other clinicians rather than replace them.